3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
2
Weight Gain
1
Peripheral Nervous System Diseases
1
Overweight
1
Obesity
1
Myasthenia Gravis
1
Infertility
1
Endometrial Neoplasms
1
Interventions
zilucoplan
1
tocilizumab
1
rozanolixizumab
1
fludarabine
1
blinatumomab
1
Tablets
1
Cyclophosphamide
1
Albuterol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Myasthenia Gravis
×
Tablets
×
Clear all
NCT03914638
2020-04-06
BETA-MG
University of Aarhus
Phase 2/3
Unknown
30 enrolled